Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Geneos Therapeutics logo — Developing the next generation of patient specific neoantige...

Geneos Therapeutics

Developing the next generation of patient specific neoantigen-targeting cancer immunotherapies, one patient at a time.

Founded 2016 United States United States 13 employees Series A Total: $49.50M Biotechnology, Health Care +2

General Information

Company Name Geneos Therapeutics
Founded Year 2016
Location United States United States +1
Founders / Decision Makers
Team member
Employees 13
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series A
Social

Get notified when Geneos Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Geneos Therapeutics

Geneos Therapeutics is a biotechnology startup founded in 2016 with a mission to develop the next generation of patient-specific neoantigen-targeting cancer immunotherapies, as reflected in their slogan, "Developing the next generation of patient-specific neoantigen-targeting cancer immunotherapies, one patient at a time." Headquartered in the United States, the company aims to harness the body’s own immune system to combat cancer. Their GT-EPIC Platform is designed to identify relevant neoantigen targets and then to design, manufacture, and deliver tumor-specific neoantigen-targeted personalized immunotherapies. This innovative approach has garnered investor interest, as evidenced by the $5.00M Series A investment secured on 27 September 2023 from Shanghai Healthcare Capital. Geneos Therapeutics operates at the forefront of the health care and pharmaceutical industries, offering a promising solution in the fight against cancer.

Taxonomy: cancer immunotherapy, personalized therapy, neoantigen-targeting, immune system activation, patient-specific treatment

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
27 Sep 2023
Series A •••••• 1
Investor
12 Apr 2023
Series A •••••• 5
Investor Investor Investor
•••• •••• 		24 Mar 2022
Series A •••••• 3
Investor Investor
•••• •••• 		03 Mar 2021
Series A •••••• - 21 Feb 2019

Geneos Therapeutics Alternatives & Competitors

Geneos Therapeutics vs
BioVaxys Technology Corp.
BioVaxys Technology Corp. Canada

Antiviral and Anticancer Vaccine Platforms Harnessing the Power of T-Cells

Post Ipo Equity
5 employees
Biopharma, Biotechnology
Geneos Therapeutics vs
NEC OncoImmunity AS
NEC OncoImmunity AS Norway

Empowering cancer immunotherapy with artificial intelligence

Seed
42 employees
AI, Biotechnology
Geneos Therapeutics vs
Likang Life Sciences
Likang Life Sciences China

Likang Life Sciences is an innovative enterprise dedicated to development of immune cell therapy, wi...

3 employees

FAQ About Geneos Therapeutics

Developing the next generation of patient specific neoantigen-targeting cancer immunotherapies, one patient at a time.
Geneos Therapeutics was founded in 2016.
Geneos Therapeutics is headquartered in United States.
Geneos Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Geneos Therapeutics has approximately 13 employees.
Geneos Therapeutics has completed 5 funding rounds, raising a total of $49.50M. The latest funding stage is Series A.
Top alternatives and competitors to Geneos Therapeutics include BioVaxys Technology Corp., NEC OncoImmunity AS, Likang Life Sciences, Neon Therapeutics, TRAINM Clinics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Geneos Therapeutics and BioVaxys Technology Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Geneos Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy